June 10, 2019 | Vensana Capital® Events

Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A